FamiCord AG
V3V
Company Profile
Business description
FamiCord AG is an umbilical cord blood bank. It supplies cryo-preservation and provides for the logistics to collect the blood, the preparation and the storage of stem cells from umbilical cord blood and tissue. The company is active in the areas of Cell & Gene therapies and CDMO. It continues to develop from a pure stem cell bank to a more broadly based cell bank that can supply the available patient’s own cells for current and future cell therapies.
Contact
Perlickstrase 5
LeipzigD-04103
DEUT: +49 3414879240
Sector
Healthcare
Stock type
Defensive
Industry
Medical Care Facilities
Fiscal Year End
31 December 2026
Employees
766
Stocks News & Analysis
stocks
10 best global blue-chip stocks to buy for the long term
The stocks of these high-quality companies with large market capitalizations look undervalued today.
stocks
3 overvalued ASX shares going into earnings
Prices of these shares exceed our Fair Value Estimate by more than double.
stocks
The long-term case for compounders
Compounders tend to deliver steadier, more durable profit growth across full cycles, making them better suited for long-term investors.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,073.80 | 37.20 | -0.41% |
| CAC 40 | 8,126.53 | 55.17 | 0.68% |
| DAX 40 | 24,538.81 | 229.35 | 0.94% |
| Dow JONES (US) | 48,892.47 | 179.09 | -0.36% |
| FTSE 100 | 10,223.54 | 51.78 | 0.51% |
| HKSE | 26,906.71 | 480.40 | -1.75% |
| NASDAQ | 23,461.82 | 223.30 | -0.94% |
| Nikkei 225 | 53,482.90 | 160.05 | 0.30% |
| NZX 50 Index | 13,434.65 | 11.47 | 0.09% |
| S&P 500 | 6,939.03 | 29.98 | -0.43% |
| S&P/ASX 200 | 8,782.50 | 38.60 | -0.44% |
| SSE Composite Index | 4,086.05 | 31.89 | -0.77% |